Evidence map›Paper›PMID 26396716›Full record

ArticleMiddle East journal of digestive diseases2015

Burden of Gastrointestinal and Liver Diseases in Iran: Estimates Based on the Global Burden of Disease, Injuries, and Risk Factors Study, 2010.

Fatemeh Malekzadeh, Sadaf Ghajarieh Sepanlou, Hossein Poustchi, Mohsen Naghavi, Mohammad Hossein Forouzanfar, Saeid Shahraz, Maziar Moradi-Lakeh, Reza Malekzadeh

Open access · greenAbstract read
In one paragraph

Article in Middle East journal of digestive diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. The effects of prognostic factors on transplant and mortality of patients with end-stage liver disease using Markov multistate model.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2023
    Article
  5. Article
  6. Article
  7. Gastrointestinal endoscopy capacity in Eastern Africa.Endoscopy international open · 2021
    Article
  8. Development of Inflammatory Bowel Diseases Registry Software.Middle East journal of digestive diseases · 2021
    Article
  9. Circulating non-coding RNAs as potential diagnostic biomarkers in liver diseases.Gastroenterology and hepatology from bed to bench · 2021
    Review
  10. Burden of Liver Diseases: A Review from Iran.Middle East journal of digestive diseases · 2019
    Review
  11. Review
  12. The Evaluation of Diagnostic and Predictive Values ofIranian journal of pathology · 2018
    Article
  13. Current Challenges of Liver Transplantation in Iran.Middle East journal of digestive diseases · 2018
    Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Fatemeh MalekzadehDigestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran ; Non-Communicable Disease Research Center, Endocrine and Metabolism Research Institute, Shariati Hospital, Tehran University of medical Sciences, Tehran, Iran.
Sadaf Ghajarieh SepanlouDigestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran ; Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Shariati Hospital, Tehran university of Medical Sciences, Tehran, Iran.
Hossein PoustchiDigestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran ; Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Shariati Hospital, Tehran university of Medical Sciences, Tehran, Iran.
Mohsen NaghaviInstitute for Health Metric and Evolution, Seattle, WA, USA.
Mohammad Hossein ForouzanfarInstitute for Health Metric and Evolution, Seattle, WA, USA.
Saeid ShahrazInstitute for Clinical Research and Health Policy Studies (ICRHPS ) Tufts Medical Center,USA.
Maziar Moradi-LakehInstitute for Health Metric and Evolution, Seattle, WA, USA ; Gastrointestinal and Liver Disease Research Center (GILDRC), Iran University of Medical Sciences, Tehran, Iran.
Reza MalekzadehDigestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran ; Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Shariati Hospital, Tehran university of Medical Sciences, Tehran, Iran ; Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Shariati Hospital · IRInstitute for Health Metrics and Evaluation · USIran University of Medical Sciences · IRTufts Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Gastrointestinal and liver diseases (GILD) constitute a noteworthy portion of causes of death and disability in Iran. However, data on their prevalence and burden is sparse in Iran. The Global Burden of Disease (GBD) study in 2010 has provided invaluable comprehensive data on the burden of GILD in Iran. METHODS Estimations of death, years of life lost due to premature death (YLL), years of life lost due to disability (YLD), disability-adjusted life years (DALY), life expectancy, and healthy life expectancy have been reported for 291 diseases, 67 risk factors, 1160 sequelae, for both sexes and 19 age groups, form 1990 to 2010 for 187 countries. In the current paper, 5 major categories of gastrointestinal (GI) and liver diseases have been investigated as follows: GI infectious diseases, GI and liver cancers, liver infections, chronic end stage liver disease, and other digestive diseases. RESULTS Among women, 7.6% of all deaths and 3.9% of all DALYs were due to digestive and liver diseases in 2010. The respective figures in men were 7.8% of deaths and 4.6% of DALYs. The most important cause of death among children under 5 is diarrhea. Among adults between 15 to 49 years old, the main causes of death are GI and liver cancers and cirrhosis, while diarrhea still remains a major cause of DALY. Among adults 50 years and above, GI and liver cancers and cirrhosis are the main causes of both deaths and DALYs. Gastritis and duodenitis, diarrheal diseases, gall bladder and bile duct diseases, acute hepatitis A, peptic ulcer disease, appendicitis, and acute hepatitis A mainly cause disability rather than death. CONCLUSION GBD study provides invaluable source of data on burden of GILD in Iran. However, there exist limitations, namely overestimation of burden of liver cancer and underestimation of the burden of GI diseases that are usually diagnosed in outpatient settings. The collaboration of scientists across the world and specifically those from developing countries is necessary for improving the accuracy of future updates of GBD in these countries.

Indexed as

BurdenDisabilityGastrointestinal diseaseIranliver diseaseMortality

Identifiers

PMID26396716
PMCPMC4560628
OpenAlexW2099102856

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.